After Phase 3 depression setback, Neumora pauses two trials to make changes, scraps another
Brain health biotech Neumora has stopped two of its Phase 3 trials in major depressive disorder to make adjustments after the first late-stage study unexpectedly failed at the beginning of this year. The Watertown, MA ...
Brain health biotech Neumora has stopped two of its Phase 3 trials in major depressive disorder to make adjustments after the first late-stage study unexpectedly failed at the beginning of this year.
The Watertown, MA ...
